Literature DB >> 32220020

What dermatologists could do to cope with the novel coronavirus (SARS-CoV-2): a dermatologist's perspective from China.

H Zhang1, K Tang1, R Fang1, Q Sun1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32220020     DOI： 10.1111/jdv.16389

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN： 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  6 in total

1.  Protecting medical staff from skin injury/disease caused by personal protective equipment during epidemic period of COVID-19: experience from China.

Authors:  H Long; H Zhao; A Chen; Z Yao; B Cheng; Q Lu
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-05       Impact factor: 6.166

Review 2.  Pain Symptoms in Patients with Coronavirus Disease (COVID-19): A Literature Review.

Authors:  Lin-Man Weng; Xuan Su; Xue-Qiang Wang
Journal:  J Pain Res       Date:  2021-01-26       Impact factor: 3.133

3.  Inpatient Dermatology Consultations in a General Surgery Ward in a Tertiary Hospital in China: A Retrospective Study of 251 Patients.

Authors:  Hanlin Zhang; Keyun Tang; Rouyu Fang; Hongzhong Jin; Qiuning Sun
Journal:  Dermatol Ther (Heidelb)       Date:  2021-04-22

4.  Resuming work gradually in the context of COVID-19: Experience from a tertiary dermatology department in China.

Authors:  Keyun Tang; Hanlin Zhang; Hongzhong Jin
Journal:  Dermatol Ther       Date:  2020-06-15       Impact factor: 3.858

Review 5.  COVID-19 and dermatology: a comprehensive guide for dermatologists.

Authors:  D H Fahmy; H S El-Amawy; M A El-Samongy; A A Fouda; S H Soliman; A El-Kady; F Farnetani; A Conti; A Zoeir; A Eissa; R Eissa; S Puliatti; M C Sighinolfi; B Rocco; G Pellacani
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-06-10       Impact factor: 9.228

6.  Face the COVID-19 emergency: measures applied in an Italian Dermatologic Clinic.

Authors:  C Marasca; A Ruggiero; M C Annunziata; G Fabbrocini; M Megna
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-06       Impact factor: 9.228
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.